The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shreedhara Shetty
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shreedhara Shetty, a non-promoter shareholder of Pharmaids Pharmaceuticals Ltd, sold 8,85,000 equity shares (2.51% of total share capital) on August 18, 2025. The shares were tendered during the open offer process of the company, indicating an ongoing takeover or change-of-control situation. His holding fell from 60,10,621 shares (17.04%) to 51,25,621 shares (14.53%) post-sale. The company has a total equity share capital of ₹35.26 crore divided into 3.52 crore shares of ₹10 each.
This signals that a takeover or change-of-control event is underway at Pharmaids Pharmaceuticals, with shareholders having the opportunity to tender shares in the open offer. Existing investors should track the open offer timeline, price, and tendering window for potential exit or participation decisions.